Cancer prevention with green tea and monitoring by a new biomarker, hnRNP B1

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 480-481, Issue , 2001, Pages 299-304

  Fujiki, Hirota ^a   Suganuma, Masami ^a   Okabe, Sachiko ^a   Sueoka, Eisaburo ^b   Sueoka, Naoko ^b   Fujimoto, Nobukazu ^a   Goto, Yuri ^a   Matsuyama, Satoru ^b   Imai, Kazue ^a   Nakachi, Kei ^a  

^a SAITAMA CANCER CENTER   (Japan)

^b SAGA UNIVERSITY   (Japan)

Author keywords

10 Japanese size cups of green tea per day; Anti hnRNP B1; cDNA expression array; Combination cancer chemoprevention

Indexed keywords

ANTINEOPLASTIC AGENT; BIOCHEMICAL MARKER; COMPLEMENTARY DNA; EPIGALLOCATECHIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; PLANT EXTRACT; POLYPHENOL; SULINDAC; TAMOXIFEN;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BEVERAGE; CANCER PREVENTION; CONTROLLED STUDY; DEVICE; GENE; GENE EXPRESSION; HUMAN; INTESTINE TUMOR; LUNG CANCER; MONITORING; MOUSE; NONHUMAN; PRIORITY JOURNAL; TEA; TUMOR GROWTH;

EID: 0035451085     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(01)00189-0     Document Type: Article

References (34)

1. Mechanistic findings of green tea as cancer preventive for humans
2. Green tea and cancer chemoprevention
3. Mechanisms of cancer prevention by tea polyphenols based on inhibition of TNF-α expression
4. Antitumor promoting activity of (-)-epigallocatechin gallate, the main constituent of "tannin" in green tea
5. A new concept of tumor promotion by tumor necrosis factor-α, and cancer preventive agents (-)-epigallocatechin gallate and green tea: A review
6. A very low dose of green tea polyphenols in drinking water prevents N-methyl-N-nitrosourea-induced colon carcinogenesis in F344 rats
7. Inhibition of N-methyl-N′-nitrosoguanidine-induced carcinogenesis by (-)-epigallocatechin gallate in the rat glandular stomach
8. Some perspectives on dietary inhibition of carcinogenesis: Studies with curcumin and tea
9. Tea and cancer
10. Clinical development plan: Tea extracts green tea polyphenols epigallocatechin gallate
11. Mechanisms of growth inhibition of human lung cancer cell line, PC-9, by tea polyphenols
12. Mechanistic aspects of green tea as a cancer preventive: Effect of components on human stomach cancer cell lines
13. 3H](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue
14. Plasma and tissue levels of tea catechins in rats and mice during chronic consumption of green tea polyphenols
15. A new process of cancer prevention mediated through inhibition of tumor necrosis factor α expression
16. Profiling of gene expression in a human glioblastoma cell line using the Atlas human cDNA Expression Array 1
17. Sensitive and specific monoclonal antibody recognition of human lung cancer antigen on preserved sputum cells: A new approach to early lung cancer detection
18. Heterogeneous nuclear ribonucleoprotein B1 as a new marker of early detection for human lung cancers
19. Synergistic effects of (-)-epigallocatechin gallate with (-)-epicatechin, sulindac, or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9
20. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse
21. Combination cancer chemoprevention with green tea extract and sulindac shown in intestinal tumor formation in Min mice
22. Two stages of cancer prevention with green tea
23. Cross sectional study of effects of drinking green tea on cardiovascular and liver diseases
24. Cancer-preventive effects of drinking green tea among a Japanese population
25. Preventive effects of drinking green tea on cancer and cardiovascular disease: Epidemiological evidence for multiple targeting prevention
26. Molecular epidemiological studies on cancer prevention with green tea
27. Molecular determinants of NF-κB-inducing kinase action
28. Structure and expression of the gene (HNRPA2B1) encoding the human hnRNP protein A2/B1
29. Significance of heterogeneous nuclear ribonucleoprotein B1 as a new early detection marker for oral squamous cell carcinoma
30. Heterogeneous nuclear ribonucleoprotein B1 expressed in esophageal squamous cell carcinomas as a new biomarker for diagnosis
31. Combination chemoprevention of cancer
32. Tamoxifen for prevention of breast cancer: Report of the National surgical adjuvant breast and bowel project P-1 study
33. Phase I trial of oral green tea extract in adult patients with solid tumors